144 related articles for article (PubMed ID: 38456333)
21. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
22. Fucoidan alleviated dextran sulfate sodium-induced ulcerative colitis with improved intestinal barrier, reshaped gut microbiota composition, and promoted autophagy in male C57BL/6 mice.
Li S; Qian Q; Yang H; Wu Z; Xie Y; Yin Y; Cui Y; Li X
Nutr Res; 2024 Feb; 122():1-18. PubMed ID: 38064857
[TBL] [Abstract][Full Text] [Related]
23. Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice.
Chen LM; Yang PP; Al Haq AT; Hwang PA; Lai YC; Weng YS; Chen MA; Hsu HL
J Biomed Sci; 2022 Sep; 29(1):70. PubMed ID: 36109724
[TBL] [Abstract][Full Text] [Related]
24. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn's disease.
Han B; Tang D; Lv X; Fan J; Li S; Zhu H; Zhang J; Xu S; Xu X; Huang Z; Huang Z; Lin G; Zhan L; Lv X
Gut Microbes; 2024; 16(1):2310894. PubMed ID: 38312103
[TBL] [Abstract][Full Text] [Related]
25. Effects of fucoidan on gut flora and tumor prevention in 1,2-dimethylhydrazine-induced colorectal carcinogenesis.
Xue M; Liang H; Ji X; Zhou Z; Liu Y; Sun T; Zhang L
J Nutr Biochem; 2020 Aug; 82():108396. PubMed ID: 32388163
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Gut Microbiota: A Novel Paradigm of Enhancing the Efficacy of Programmed Death-1 and Programmed Death Ligand-1 Blockade Therapy.
Wang Y; Ma R; Liu F; Lee SA; Zhang L
Front Immunol; 2018; 9():374. PubMed ID: 29556232
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy.
Knudson KM; Hicks KC; Alter S; Schlom J; Gameiro SR
J Immunother Cancer; 2019 Mar; 7(1):82. PubMed ID: 30898149
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
[TBL] [Abstract][Full Text] [Related]
29. The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes: A focus on solid tumors.
Najafi S; Majidpoor J; Mortezaee K
Life Sci; 2022 Dec; 310():121138. PubMed ID: 36309224
[TBL] [Abstract][Full Text] [Related]
30. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
31.
Chu C; Yu L; Li Y; Guo H; Zhai Q; Chen W; Tian F
Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049578
[TBL] [Abstract][Full Text] [Related]
32. Effects of a polysaccharide-rich extract derived from Irish-sourced Laminaria digitata on the composition and metabolic activity of the human gut microbiota using an in vitro colonic model.
Strain CR; Collins KC; Naughton V; McSorley EM; Stanton C; Smyth TJ; Soler-Vila A; Rea MC; Ross PR; Cherry P; Allsopp PJ
Eur J Nutr; 2020 Feb; 59(1):309-325. PubMed ID: 30805695
[TBL] [Abstract][Full Text] [Related]
33. Diet, Microbiome, and Cancer Immunotherapy-A Comprehensive Review.
Szczyrek M; Bitkowska P; Chunowski P; Czuchryta P; Krawczyk P; Milanowski J
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34203292
[TBL] [Abstract][Full Text] [Related]
34. Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolites.
Gao G; Shen S; Zhang T; Zhang J; Huang S; Sun Z; Zhang H
EBioMedicine; 2023 May; 91():104533. PubMed ID: 37027929
[TBL] [Abstract][Full Text] [Related]
35. Association of microbiota with cancer treatment.
Yoshimura K
Int J Clin Oncol; 2023 Mar; 28(3):341-346. PubMed ID: 36843139
[TBL] [Abstract][Full Text] [Related]
36. Effects of Fucoidan Isolated From
Tang Y; Pu Q; Zhao Q; Zhou Y; Jiang X; Han T
Front Immunol; 2022; 13():916618. PubMed ID: 35664002
[TBL] [Abstract][Full Text] [Related]
37. Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity.
Sergeev IN; Aljutaily T; Walton G; Huarte E
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31952249
[TBL] [Abstract][Full Text] [Related]
38. Gut Microbiota Modulation in the Context of Immune-Related Aspects of
Kaźmierczak-Siedlecka K; Roviello G; Catalano M; Polom K
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444834
[TBL] [Abstract][Full Text] [Related]
39. In vitro human gut microbiota fermentation of litchi pulp polysaccharides as affected by Lactobacillus pre-treatment.
Xia C; Zhang R; Jia X; Dong L; Ma Q; Zhao D; Kun Lee Y; Sun Z; Huang F; Zhang M
Food Chem; 2024 Jul; 445():138734. PubMed ID: 38401310
[TBL] [Abstract][Full Text] [Related]
40. Microbiome analysis combined with targeted metabolomics reveal immunological anti-tumor activity of icariside I in a melanoma mouse model.
Chen G; Cao Z; Shi Z; Lei H; Chen C; Yuan P; Wu F; Liu C; Dong M; Song Y; Zhou J; Lu Y; Zhang L
Biomed Pharmacother; 2021 Aug; 140():111542. PubMed ID: 34088571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
